Nuclear and extranuclear effects of vitamin A

Canadian Journal of Physiology and Pharmacology

Volumn 93, Issue 12, 2015, Pages 1065-1075

  Iskakova, Madina ^a   Karbyshev, Mikhail ^a   Piskunov, Aleksandr ^a   Rochette Egly, Cécile ^b  

^a International Biotechnology Center Generium   (Russian Federation)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Phosphorylation; Retinoic acid; Signaling; Transcription; Vitamin A

Indexed keywords

HISTONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOTRANSFERASE; RETINOIC ACID RECEPTOR; RETINOL; CELL RECEPTOR; TRANSCRIPTION FACTOR;

DNA BINDING; DRUG EFFECT; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; DRUG EFFECTS; METABOLISM;

ANIMALS; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; VITAMIN A;

EID: 84947582136     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0522     Document Type: Review

References (125)

1. Al Tanoury, Z., Piskunov, A., and Rochette-Egly, C. 2013. Vitamin A and retinoid signaling: genomic and nongenomic effects. J. Lipid Res. 54: 1761-1775. doi: 10.1194/jlr.R030833. PMID:23440512.
2. Al Tanoury, Z., Gaouar, S., Piskunov, A., Ye, T., Urban, S., Jost, B., et al. 2014. Phosphorylation of the retinoic acid receptor RARgamma2 is crucial for the neuronal differentiation of mouse embryonic stem cells. J. Cell Sci. 127: 2095-2105. doi:10.1242/jcs.145979. PMID:24569880.
3. Al Tanoury, Z., Piskunov, A., Andriamoratsiresy, D., Gaouar, S., Lutzing, R., Ye, T., et al. 2014b. Genes involved in cell adhesion and signaling: a new repertoire of retinoic acid receptor target genes in mouse embryonic fibroblasts. J. Cell Sci. 127: 521-533. doi:10.1242/jcs.131946. PMID:24357724.
4. Alsayed, Y., Uddin, S., Mahmud, N., Lekmine, F., Kalvakolanu, D.V., Minucci, S., et al. 2001. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J. Biol. Chem. 276: 4012-4019. doi:10.1074/jbc.M007431200. PMID:11060298.
5. Aoto, J., Nam, C.I., Poon, M.M., Ting, P., and Chen, L. 2008. Synaptic signaling by all-trans retinoic acid in homeostatic synaptic plasticity. Neuron, 60: 308-320. doi:10.1016/j.neuron.2008.08.012. PMID:18957222.
6. Bain, D.L., Heneghan, A.F., Connaghan-Jones, K.D., and Miura, M.T. 2007. Nuclear receptor structure: implications for function. Annu. Rev. Physiol. 69: 201-220. doi:10.1146/annurev.physiol.69.031905.160308. PMID:17137423.
7. Ball, L.J., Kuhne, R., Schneider-Mergener, J., and Oschkinat, H. 2005. Recognition of proline-rich motifs by protein-protein-interaction domains. Angew. Chem. Int. Ed. Engl. 44: 2852-2869. doi:10.1002/anie.200400618. PMID:15880548.
8. Bastien, J., and Rochette-Egly, C. 2004. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene, 328: 1-16. doi:10.1016/j.gene.2003.12.005. PMID:15019979.
9. Bastien, J., Adam-Stitah, S., Riedl, T., Egly, J.M., Chambon, P., and Rochette-Egly, C. 2000. TFIIH interacts with the retinoic acid receptor gamma and phosphorylates its AF-1-activating domain through cdk7. J. Biol. Chem. 275: 21896-21904. doi: 10.1074/jbc.M001985200. PMID:10748061.
10. Berry, D.C., and Noy, N. 2009. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor. Mol. Cell. Biol. 29: 3286-3296. doi:10.1128/MCB.01742-08. PMID:19364826.
11. Berry, D.C., and Noy, N. 2012. Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis. Biochim. Biophys. Acta, 1821: 168-176. doi:10.1016/j.bbalip.2011.07.002. PMID:21782034.
12. Berry, D.C., Jin, H., Majumdar, A., and Noy, N. 2011. Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses. Proc. Natl. Acad. Sci. U.S.A. 108: 4340-4345. doi:10.1073/pnas.1011115108. PMID:21368206.
13. Blomhoff, R. 1994. Transport and metabolism of vitamin A. Nutr. Rev. 52: S13-S23. doi:10.1111/j.1753-4887.1994.tb01382.x. PMID:8202278.
14. Bour, G., Gaillard, E., Bruck, N., Lalevee, S., Plassat, J.L., Busso, D., et al. 2005a. Cyclin H binding to the RARalpha activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7. Proc. Natl. Acad. Sci. U.S.A. 102: 16608-16613. doi:10.1073/pnas.0505556102. PMID: 16275922.
15. Bour, G., Plassat, J.L., Bauer, A., Lalevee, S., and Rochette-Egly, C. 2005b. Vinexin beta interacts with the non-phosphorylated AF-1 domain of retinoid receptor gamma (RARgamma) and represses RARgamma-mediated transcription. J. Biol. Chem. 280: 17027-17037. doi:10.1074/jbc.M501344200. PMID:15734736.
16. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H., and Moras, D. 1995. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature, 375: 377-382. doi:10.1038/375377a0. PMID:7760929.
17. Bourguet, W., Germain, P., and Gronemeyer, H. 2000. Nuclear receptor ligandbinding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol. Sci. 21: 381-388. doi:10.1016/S0165-6147(00)01548-0. PMID:11050318.
18. Brondani, V., Schefer, Q., Hamy, F., and Klimkait, T. 2005. The peptidyl-prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor alpha stability. Biochem. Biophys. Res. Commun. 328: 6-13. doi:10.1016/j.bbrc.2004.12.130. PMID:15670742.
19. Bruck, N., Vitoux, D., Ferry, C., Duong, V., Bauer, A., de The, H., and Rochette-Egly, C. 2009. A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters. EMBO J. 28: 34-47. doi:10.1038/emboj.2008.256. PMID:19078967.
20. Budhu, A.S., and Noy, N. 2002. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol. Cell. Biol. 22: 2632-2641. doi:10.1128/MCB.22.8.2632-2641.2002. PMID:11909957.
21. Castoria, G., Lombardi, M., Barone, M.V., Bilancio, A., Di Domenico, M., Bottero, D., et al. 2003. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J. Cell Biol. 161: 547-556. doi:10.1083/jcb.200211099. PMID:12743104.
22. Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10: 940-954. PMID:8801176.
23. Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T.P., and Rastinejad, F. 2008. Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature, 456: 350-356. doi:10.1038/nature07413. PMID: 19043829.
24. Chebaro, Y., Amal, I., Rochel, N., Rochette-Egly, C., Stote, R.H., and Dejaegere, A. 2013. Phosphorylation of the retinoic acid receptor alpha induces a mechanical allosteric regulation and changes in internal dynamics. PLoS Comput. Biol. 9: e1003012. doi:10.1371/journal.pcbi.1003012. PMID:23637584.
25. Chen, N., and Napoli, J.L. 2008. All-trans-retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membraneassociated RARalpha. FASEB J. 22: 236-245. doi:10.1096/fj.07-8739com. PMID: 17712061.
26. Cheung, Y.T., Lau, W.K., Yu, M.S., Lai, C.S., Yeung, S.C., So, K.F., and Chang, R.C. 2009. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology, 30: 127-135. doi: 10.1016/j.neuro.2008.11.001. PMID:19056420.
27. Combs, G.F. 2007. The Vitamins. Elsevier Science.
28. de Laurentiis, A., Donovan, L., and Arcaro, A. 2007. Lipid rafts and caveolae in signaling by growth factor receptors. Open Biochem. J. 1: 12-32. doi:10.2174/1874091X00701010012. PMID:18949068.
29. Delva, L., Bastie, J.N., Rochette-Egly, C., Kraiba, R., Balitrand, N., Despouy, G., et al. 1999. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol. Cell. Biol. 19: 7158-7167. PMID:10490651.
30. Dilworth, F.J., and Chambon, P. 2001. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene, 20: 3047-3054. doi:10.1038/sj.onc.1204329. PMID: 11420720.
31. Duester, G. 2008. Retinoic acid synthesis and signaling during early organogenesis. Cell, 134: 921-931. doi:10.1016/j.cell.2008.09.002. PMID:18805086.
32. Dyson, H.J., and Wright, P.E. 2005. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6: 197-208. doi:10.1038/nrm1589. PMID: 15738986.
33. Egea, P.F., Rochel, N., Birck, C., Vachette, P., Timmins, P.A., and Moras, D. 2001. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J. Mol. Biol. 307: 557-576. doi:10.1006/jmbi.2000.4409. PMID:11254382.
34. Farboud, B., and Privalsky, M.L. 2004. Retinoic acid receptor-alpha is stabilized in a repressive state by its C-terminal, isotype-specific F domain. Mol. Endocrinol. 18: 2839-2853. doi:10.1210/me.2004-0236. PMID:15331758.
35. Fraser, P.D., and Bramley, P.M. 2004. The biosynthesis and nutritional uses of carotenoids. Prog. Lipid Res. 43: 228-265. doi:10.1016/j.plipres.2003.10.002. PMID:15003396.
36. Gaillard, E., Bruck, N., Brelivet, Y., Bour, G., Lalevee, S., Bauer, A., et al. 2006. Phosphorylation by PKA potentiates retinoic acid receptor alpha activity by means of increasing interaction with and phosphorylation by cyclin H/cdk7. Proc. Natl. Acad. Sci. U.S.A. 103: 9548-9553. doi:10.1073/pnas.0509717103. PMID:16769902.
37. Gehani, S.S., Agrawal-Singh, S., Dietrich, N., Christophersen, N.S., Helin, K., and Hansen, K. 2010. Polycomb group protein displacement and gene activation through MSK-dependent H3K27me3S28 phosphorylation. Mol. Cell, 39: 886-900. doi:10.1016/j.molcel.2010.08.020. PMID:20864036.
38. Gianni, M., Bauer, A., Garattini, E., Chambon, P., and Rochette-Egly, C. 2002. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation. EMBO J. 21: 3760-3769. doi:10.1093/emboj/cdf374. PMID:12110588.
39. Gianni, M., Parrella, E., Raska, I., Jr., Gaillard, E., Nigro, E.A., Gaudon, C., et al. 2006. P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARalpha-mediated transcription. EMBO J. 25: 739-751. doi:10.1038/sj.emboj.7600981. PMID:16456540.
40. Gianni, M., Boldetti, A., Guarnaccia, V., Rambaldi, A., Parrella, E., Raska, I., Jr., et al. 2009. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha. Cancer Res. 69: 1016-1026. doi:10.1158/0008-5472.CAN-08-2603. PMID:19155306.
41. Gillespie, R.F., and Gudas, L.J. 2007. Retinoic acid receptor isotype specificity in F9 teratocarcinoma stem cells results from the differential recruitment of coregulators to retinoic response elements. J. Biol. Chem. 282: 33421-33434. doi:10.1074/jbc.M704845200. PMID:17875646.
42. Glass, C.K. 1994. Differential Recognition of Target Genes by Nuclear Receptor Monomers, Dimers, and Heterodimers. Endocr. Rev. 15: 391-407. doi:10.1210/edrv-15-3-391. PMID:8076589.
43. Glass, C.K., and Rosenfeld, M.G. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14: 121-141. doi:10.1101/gad.14.2.121. PMID:10652267.
44. Gudas, L.J., and Wagner, J.A. 2011. Retinoids regulate stem cell differentiation. J. Cell. Physiol. 226: 322-330. doi:10.1002/jcp.22417. PMID:20836077.
45. Gupta, P., Ho, P.C., Huq, M.M., Ha, S.G., Park, S.W., Khan, A.A., et al. 2008. Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression. Proc. Natl. Acad. Sci. U.S.A. 105: 11424-11429. doi:10.1073/pnas.0710561105. PMID: 18682553.
46. Hagan, C.R., Faivre, E.J., and Lange, C.A. 2009. Scaffolding actions of membraneassociated progesterone receptors. Steroids, 74: 568-572. doi:10.1016/j.steroids.2008.12.004. PMID:19135465.
47. Hamy, F., Verwaerde, P., Helbecque, N., Formstecher, P., and Henichart, J.P. 1991. Nuclear Targeting of a Viral-Cointernalized Protein by a Short Signal Sequence from Human Retinoic Acid Receptors. Bioconjug. Chem. 2: 375-378. doi:10.1021/bc00011a013. PMID:1665078.
48. Ju, B.G., and Rosenfeld, M.G. 2006. A breaking strategy for topoisomerase IIbeta/ PARP-1-dependent regulated transcription. Cell Cycle, 5: 2557-2560. doi:10.4161/cc.5.22.3497. PMID:17106262.
49. Kashyap, V., and Gudas, L.J. 2010. Epigenetic regulatory mechanisms distinguish retinoic acid-mediated transcriptional responses in stem cells and fibroblasts. J. Biol. Chem. 285: 14534-14548. doi:10.1074/jbc.M110.115345. PMID: 20231276.
50. Kashyap, V., Laursen, K.B., Brenet, F., Viale, A.J., Scandura, J.M., and Gudas, L.J. 2013. RARgamma is essential for retinoic acid induced chromatin remodeling and transcriptional activation in embryonic stem cells. J. Cell Sci. 126: 999-1008. doi:10.1242/jcs.119701. PMID:23264745.
51. Kastner, P., Mark, M., and Chambon, P. 1995. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell, 83: 859-869. doi:10.1016/0092-8674(95)90202-3. PMID:8521510.
52. Kawaguchi, R., Yu, J., Honda, J., Hu, J., Whitelegge, J., Ping, P., et al. 2007. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science, 315: 820-825. doi:10.1126/science.1136244. PMID: 17255476.
53. Kay, B.K., Williamson, M.P., and Sudol, M. 2000a. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14: 231-241. PMID:10657980.
54. Kay, B.K., Williamson, M.P., and Sudol, P. 2000b. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14: 231-241. PMID:10657980.
55. Kedishvili, N.Y. 2013. Enzymology of retinoic acid biosynthesis and degradation. J. Lipid Res. 54: 1744-1760. doi:10.1194/jlr.R037028. PMID:23630397.
56. Keriel, A., Stary, A., Sarasin, A., Rochette-Egly, C., and Egly, J.M. 2002. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell, 109: 125-135. doi:10.1016/S0092-8674(02)00692-X. PMID:11955452.
57. Lalevee, S., Bour, G., Quinternet, M., Samarut, E., Kessler, P., Vitorino, M., et al. 2010. Vinexinss, an atypical “sensor” of retinoic acid receptor gamma signaling: union and sequestration, separation, and phosphorylation. FASEB J. 24: 4523-4534. doi:10.1096/fj.10-160572. PMID:20634350.
58. Lane, M.A., and Bailey, S.J. 2005. Role of retinoid signalling in the adult brain. Prog. Neurobiol. 75: 275-293. doi:10.1016/j.pneurobio.2005.03.002. PMID: 15882777.
59. Laudet, V., and Gronemeyer, H. 2002. The nuclear receptor factsbook. Academic Press.
60. Le Maire, A., Teyssier, C., Erb, C., Grimaldi, M., Alvarez, S., de Lera, A.R., et al. 2010. A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor. Nat. Struct. Mol. Biol. 17: 801-807. doi:10.1038/nsmb.1855. PMID:20543827.
61. Lee, M.S., Kliewer, S.A., Provencal, J., Wright, P.E., and Evans, R.M. 1993. Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. Science, 260: 1117-1121. doi:10.1126/science.8388124. PMID:8388124.
62. Lee, M.G., Villa, R., Trojer, P., Norman, J., Yan, K.P., Reinberg, D., et al. 2007. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science, 318: 447-450. doi:10.1126/science.1149042. PMID:17761849.
63. Li, Y., Lambert, M.H., and Xu, H.E. 2003. Activation of nuclear receptors: a perspective from structural genomics. Structure, 11: 741-746. doi:10.1016/S0969-2126(03)00133-3. PMID:12842037.
64. Liu, J., Perumal, N.B., Oldfield, C.J., Su, E.W., Uversky, V.N., and Dunker, A.K. 2006. Intrinsic disorder in transcription factors. Biochemistry, 45: 6873-6888. doi:10.1021/bi0602718. PMID:16734424.
65. Luoma, J.I., Boulware, M.I., and Mermelstein, P.G. 2008. Caveolin proteins and estrogen signaling in the brain. Mol. Cell. Endocrinol. 290: 8-13. doi:10.1016/j.mce.2008.04.005. PMID:18502030.
66. Macias, M.J., Wiesner, S., and Sudol, M. 2002.WWand SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett. 513: 30-37. doi:10.1016/S0014-5793(01)03290-2. PMID:11911877.
67. Mahony, S., Mazzoni, E.O., McCuine, S., Young, R.A., Wichterle, H., and Gifford, D.K. 2011. Ligand-dependent dynamics of retinoic acid receptor binding during early neurogenesis. Genome Biol. 12: R2. doi:10.1186/gb-2011-12-1-r2. PMID:21232103.
68. Mark, M., Ghyselinck, N.B., and Chambon, P. 2006. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu. Rev. Pharmacol. Toxicol. 46: 451-480. doi:10.1146/annurev.pharmtox.46.120604.141156. PMID:16402912.
69. Marquez, D.C., Chen, H.W., Curran, E.M., Welshons, W.V., and Pietras, R.J. 2006. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol. Cell. Endocrinol. 246: 91-100. doi:10.1016/j.mce.2005.11.020. PMID:16388889.
70. Masia, S., Alvarez, S., de Lera, A.R., and Barettino, D. 2007. Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. Mol. Endocrinol. 21: 2391-2402. doi: 10.1210/me.2007-0062. PMID:17595318.
71. Matthews, L., Berry, A., Ohanian, V., Ohanian, J., Garside, H., and Ray, D. 2008. Caveolin mediates rapid glucocorticoid effects and couples glucocorticoid action to the antiproliferative program. Mol. Endocrinol. 22: 1320-1330. doi: 10.1210/me.2007-0154. PMID:18308897.
72. Mendoza-Parra, M.A., and Gronemeyer, H. 2013. Genome-wide studies of nuclear receptors in cell fate decisions. Semin. Cell Dev. Biol. 24: 706-715. doi:10.1016/j.semcdb.2013.07.001. PMID:23916718.
73. Mendoza-Parra, M.A., Walia, M., Sankar, M., and Gronemeyer, H. 2011. Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics. Mol. Syst. Biol. 7: 538. doi:10.1038/msb.2011.73. PMID: 21988834.
74. Migliaccio, A., Piccolo, D., Castoria, G., Di Domenico, M., Bilancio, A., Lombardi, M., et al. 1998. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17: 2008-2018. doi:10.1093/emboj/17.7.2008. PMID:9524123.
75. Migliaccio, A., Castoria, G., Di Domenico, M., de Falco, A., Bilancio, A., Lombardi, M., et al. 2000. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J. 19: 5406-5417. doi:10.1093/emboj/19.20.5406. PMID:11032808.
76. Moras, D., and Gronemeyer, H. 1998. The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10: 384-391. doi:10.1016/S0955-0674(98)80015-X. PMID:9640540.
77. Morriss-Kay, G.M., and Ward, S.J. 1999. Retinoids and mammalian development. Int. Rev. Cytol. 188: 73-131. doi:10.1016/S0074-7696(08)61566-1. PMID: 10208011.
78. Moutier, E., Ye, T., Choukrallah, M.A., Urban, S., Osz, J., Chatagnon, A., et al. 2012. Retinoic acid receptors recognize the mouse genome through binding elements with diverse spacing and topology. J. Biol. Chem. 287: 26328-26341. doi:10.1074/jbc.M112.361790. PMID:22661711.
79. Nagpal, S., Friant, S., Nakshatri, H., and Chambon, P. 1993. RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO J. 12: 2349-2360. PMID:8389696.
80. Nakayama, T.A., and Khorana, H.G. 1990. Orientation of retinal in bovine rhodopsin determined by cross-linking using a photoactivatable analog of 11-cisretinal. J. Biol. Chem. 265: 15762-15769. PMID:2144289.
81. Napoli, J.L. 2012. Physiological insights into all-trans-retinoic acid biosynthesis. Biochim. Biophys. Acta, 1821: 152-167. doi:10.1016/j.bbalip.2011.05.004. PMID: 21621639.
82. Norman, A.W., Mizwicki, M.T., and Norman, D.P. 2004. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat. Rev. Drug Discov. 3: 27-41. doi:10.1038/nrd1283. PMID:14708019.
83. Noy, N. 1992. The ionization behavior of retinoic acid in lipid bilayers and in membranes. Biochim. Biophys. Acta, 1106: 159-164. doi:10.1016/0005-2736(92)90234-D. PMID:1581329.
84. Noy, N., and Xu, Z.J. 1990. Thermodynamic parameters of the binding of retinol to binding proteins and to membranes. Biochemistry, 29: 3888-3892. doi:10.1021/bi00468a014. PMID:2354160.
85. O’Byrne, S.M., and Blaner, W.S. 2013. Retinol and retinyl esters: biochemistry and physiology. J. Lipid Res. 54: 1731-1743. doi:10.1194/jlr.R037648. PMID: 23625372.
86. Ong, D.E., Davis, J.T., O’Day, W.T., and Bok, D. 1994. Synthesis and secretion of retinol-binding protein and transthyretin by cultured retinal pigment epithelium. Biochemistry, 33: 1835-1842. doi:10.1021/bi00173a029. PMID: 8110786.
87. Pan, J., Kao, Y.L., Joshi, S., Jeetendran, S., Dipette, D., and Singh, U.S. 2005. Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acidinduced neuronal differentiation of SH-SY5Y cells. J. Neurochem. 93: 571-583. doi:10.1111/j.1471-4159.2005.03106.x. PMID:15836616.
88. Perissi, V., and Rosenfeld, M.G. 2005. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol. 6: 542-554. doi:10.1038/nrm1680. PMID:15957004.
89. Perissi, V., Staszewski, L.M., McInerney, E.M., Kurokawa, R., Krones, A., Rose, D.W., et al. 1999. Molecular determinants of nuclear receptorcorepressor interaction. Genes Dev. 13: 3198-3208. doi:10.1101/gad.13.24.3198. PMID:10617569.
90. Perissi, V., Jepsen, K., Glass, C.K., and Rosenfeld, M.G. 2010. Deconstructing repression: evolving models of co-repressor action. Nat. Rev. Genet. 11: 109-123. doi:10.1038/ni0210-109,10.1038/nrg2736. PMID:20084085.
91. Persaud, S.D., Lin, Y.W., Wu, C.Y., Kagechika, H., and Wei, L.N. 2013. Cellular retinoic acid binding protein I mediates rapid non-canonical activation of ERK1/2 by all-trans retinoic acid. Cell Signal. 25: 19-25. doi:10.1016/j.cellsig.2012.09.002. PMID:22982089.
92. Piskunov, A., and Rochette-Egly, C. 2012a. A retinoic acid receptor RARalpha pool present in membrane lipid rafts forms complexes with G protein alphaQ to activate p38MAPK. Oncogene, 31: 3333-3345. doi:10.1038/onc.2011.499. PMID:22056876.
93. Piskunov, A., and Rochette-Egly, C. 2012b. MSK1 and nuclear receptor signaling. MSKs. Edited by S. Arthur and L. Vermeulen. Austin: Landes Biosciences.
94. Poon, M.M., and Chen, L. 2008. Retinoic acid-gated sequence-specific translational control by RARalpha. Proc. Natl. Acad. Sci. U.S.A. 105: 20303-20308. doi:10.1073/pnas.0807740105. PMID:19073915.
95. Pufall, M.A., Lee, G.M., Nelson, M.L., Kang, H.S., Velyvis, A., Kay, L.E., et al. 2005. Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region. Science, 309: 142-145. doi:10.1126/science.1111915. PMID: 15994560.
96. Reid, J., Kelly, S.M., Watt, K., Price, N.C., and McEwan, I.J. 2002. Conformational analysis of the androgen receptor amino-terminal domain involved in transactivation. Influence of structure-stabilizing solutes and protein-protein interactions. J. Biol. Chem. 277: 20079-20086. doi:10.1074/jbc.M201003200. PMID:11896058.
97. Ren, X., Li, Y., Ma, X., Zheng, L., Xu, Y., and Wang, J. 2007. Activation of p38/ MEF2C pathway by all-trans retinoic acid in cardiac myoblasts. Life Sci. 81: 89-96. doi:10.1016/j.lfs.2007.04.03. PMID:17568621.
98. Renaud, J.P., and Moras, D. 2000. Structural studies on nuclear receptors. Cell. Mol. Life Sci. 57: 1748-1769. doi:10.1007/PL00000656. PMID:11130180.
99. Renaud, J.P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H., and Moras, D. 1995. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature, 378: 681-689. doi:10.1038/378681a0. PMID:7501014.
100. Rochel, N., and Moras, D. 2014. Architecture of DNA Bound RAR heterodimers. Subcell. Biochem. 70: 21-36. doi:10.1007/978-94-017-9050-5_2. PMID:24962879.
101. Rochel, N., Ciesielski, F., Godet, J., Moman, E., Roessle, M., Peluso-Iltis, C., et al. 2011. Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings. Nat. Struct. Mol. Biol. 18: 564-570. doi:10.1038/nsmb.2054. PMID:21478865.
102. Rochette-Egly, C. 2003. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell Signal. 15: 355-366. doi:10.1016/S0898-6568(02)00115-8. PMID:12618210.
103. Rochette-Egly, C., and Germain, P. 2009. Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). Nucl. Recept. Signal. 7: e005. doi:10.1621/nrs.07005. PMID:19471584.
104. Rochette-Egly, C., Oulad-Abdelghani, M., Staub, A., Pfister, V., Scheuer, I., Chambon, P., and Gaub, M.P. 1995. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Mol. Endocrinol. 9: 860-871. doi:10.1210/mend.9.7.7476969. PMID:7476969.
105. Rochette-Egly, C., Adam, S., Rossignol, M., Egly, J.M., and Chambon, P. 1997. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell, 90: 97-107. doi:10.1016/S0092-8674(00)80317-7. PMID:9230306.
106. Ruiz, A., Mark, M., Jacobs, H., Klopfenstein, M., Hu, J., Lloyd, M., et al. 2012. Retinoid content, visual responses, and ocular morphology are compromised in the retinas of mice lacking the retinol-binding protein receptor, STRA6. Invest. Ophthalmol. Vis. Sci. 53: 3027-3039. doi:10.1167/iovs.11-8476. PMID: 22467576.
107. Samarut, E., Amal, I., Markov, G.V., Stote, R., Dejaegere, A., Laudet, V., and Rochette-Egly, C. 2011. Evolution of nuclear retinoic acid receptor alpha (RARalpha) phosphorylation sites. Serine gain provides fine-tuned regulation. Mol. Biol. Evol. 28: 2125-2137. doi:10.1093/molbev/msr035. PMID: 21297158.
108. Schug, T.T., Berry, D.C., Shaw, N.S., Travis, S.N., and Noy, N. 2007. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell, 129: 723-733. doi:10.1016/j.cell.2007.02.050. PMID:17512406.
109. Schug, T.T., Berry, D.C., Toshkov, I.A., Cheng, L., Nikitin, A.Y., and Noy, N. 2008. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proc. Natl. Acad. Sci. U.S.A. 105: 7546-7551. doi:10.1073/pnas.0709981105. PMID:18495924.
110. Shirakami, Y., Lee, S.A., Clugston, R.D., and Blaner, W.S. 2012. Hepatic metabolism of retinoids and disease associations. Biochim. Biophys. Acta, 1821: 124-136. doi:10.1016/j.bbalip.2011.06.023. PMID:21763780.
111. Sommer, A., and West, K.P. 1996. Vitamin A Deficiency: Health, Survival, and Vision. Oxford University Press.
112. Srinivas, H., Juroske, D.M., Kalyankrishna, S., Cody, D.D., Price, R.E., Xu, X.C., et al. 2005. c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha. Mol. Cell. Biol. 25: 1054-1069. doi:10.1128/MCB.25.3.1054-1069.2005. PMID:15657432.
113. Stavridis, M.P., Collins, B.J., and Storey, K.G. 2010. Retinoic acid orchestrates fibroblast growth factor signalling to drive embryonic stem cell differentiation. Development, 137: 881-890. doi:10.1242/dev.043117. PMID:20179094.
114. Steinmetz, A.C., Renaud, J.P., and Moras, D. 2001. Binding of ligands and activation of transcription by nuclear receptors. Annu. Rev. Biophys. Biomol. Struct. 30: 329-359. doi:10.1146/annurev.biophys.30.1.329. PMID:11340063.
115. Stipanuk, M.H., and Caudill, M.A. 2013. Biochemical, Physiological, and Molecular Aspects of Human Nutrition. Elsevier Health Sciences.
116. Sudol, M., Sliwa, K., and Russo, T. 2001. Functions of WW domains in the nucleus. FEBS Lett. 490: 190-195. doi:10.1016/S0014-5793(01)02122-6. PMID: 11223034.
117. Taneja, R., Rochette-Egly, C., Plassat, J.L., Penna, L., Gaub, M.P., and Chambon, P. 1997. Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO J. 16: 6452-6465. doi:10.1093/emboj/16.21.6452. PMID:9351827.
118. Warnmark, A., Treuter, E., Wright, A.P., and Gustafsson, J.A. 2003. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol. Endocrinol. 17: 1901-1909. doi:10.1210/me.2002-0384.
119. PMID:12893880.
120. World Health Organization. 1995. Global prevalence of vitamin A deficiency. Geneva.
121. Wulf, G., Finn, G., Suizu, F., and Lu, K.P. 2005. Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat. Cell Biol. 7: 435-441. doi: 10.1038/ncb0505-435. PMID:15867923.
122. Wurtz, J.M., Bourguet, W., Renaud, J.P., Vivat, V., Chambon, P., Moras, D., and Gronemeyer, H. 1996. A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3: 87-94. doi:10.1038/nsb0196-87. PMID: 8548460.
123. Zarrinpar, A., and Lim, W.A. 2000. Converging on proline: the mechanism of WW domain peptide recognition. Nat. Struct. Biol. 7: 611-613. doi:10.1038/77891. PMID:10932238.
124. Zechel, C., Shen, X.Q., Chambon, P., and Gronemeyer, H. 1994a. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO J. 13: 1414-1424. PMID:8137825.
125. Zechel, C., Shen, X.Q., Chen, J.Y., Chen, Z.P., Chambon, P., and Gronemeyer, H. 1994b. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J. 13: 1425-1433. PMID: 8137826.